- Integrating non-invasive laser drug delivery technology with ECM-based biomaterials
- Full-scale expansion into the high-performance 강원 랜드 바카라 care market
[by Ji, Yong Jun] LAMEDITECH, a company specializing in laser-based healthcare technologies, announced on August 7 that it has entered into a strategic Memorandum of Understanding (MOU) with ERAETECH KOREA, a regenerative medicine biomaterials company, for the co-development and commercialization of an integrated next-generation skin booster solution.
Through this partnership, the two companies aim to actively pursue technological convergence to penetrate the high-value-added skincare medical device market. In particular, the companies plan to develop and commercialize an innovative skincare solution that offers substantially improved efficacy and delivery compared to existing products, achieved by integrating 강원 랜드 바카라's non-invasive laser drug delivery platform (DDS) with ERAETECH KOREA's high-performance skin booster, based on skin-derived extracellular matrix (ECM).
강원 랜드 바카라's drug delivery system generates microchannels without causing damage to the skin, thereby facilitating the precise penetration of active ingredients into the dermal layer. Compared with conventional topical or injection-based methods, it is regarded as a next-generation skin treatment platform that combines high efficiency, safety, and non-invasiveness.
ERAETECH KOREA, operating a research center in the GG Biohub Lab Station, has developed a high-performance 강원 랜드 바카라 boost product demonstrating outstanding effects in 강원 랜드 바카라 regeneration and elasticity improvement. Based on human-derived acellular dermal tissue and ECM biomaterials, the product differentiates itself from existing hyaluronic acid-based formulations through superior biocompatibility, safety, and long-lasting regenerative properties, and is rapidly gaining recognition and credibility in the medical field.
The two companies plan to collaborate across a broad range of initiatives, including joint product development, technology validation, and the formulation of domestic and international distribution and sales strategies, with the objective of accelerating commercialization and boost profitability. According to data from the market research firm Grand View Research, the global 강원 랜드 바카라 booster market was valued at around USD 1.36 billion (approximately KRW 1.8 trillion) in 2024.
"This collaboration represents the first commercial application of our DDS technology in the dermatological medical market. Leveraging our technological competitiveness, we aim to accelerate the expansion of our presence in the Korean and international markets," a 강원 랜드 바카라 official stated.